The multigene classifiers 95GC/42GC/155GC for precision medicine in ER‐positive HER2‐negative early breast cancer

por Naoi, Yasuto, Tsunashima, Ryo, Shimazu, Kenzo, Noguchi, Shinzaburo
Publicado 2021

Radiogenomics of magnetic resonance imaging and a new multi-gene classifier for predicting recurrence prognosis in estrogen receptor-positive breast cancer: A preliminary study

por Tokuda, Yukiko, Yanagawa, Masahiro, Minamitani, Kaori, Naoi, Yasuto, Noguchi, Shinzaburo, Tomiyama, Noriyuki
Publicado 2020

A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer

por Abe, Kaori, Shimoda, Masafumi, Yoshinami, Tetsuhiro, Sota, Yoshiaki, Miyake, Tomohiro, Tanei, Tomonori, Kagara, Naofumi, Naoi, Yasuto, Shimazu, Kenzo
Publicado 2022

Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer

por Hori, Ami, Shimoda, Masafumi, Naoi, Yasuto, Kagara, Naofumi, Tanei, Tomonori, Miyake, Tomohiro, Shimazu, Kenzo, Kim, Seung Jin, Noguchi, Shinzaburo
Publicado 2019

Highly sensitive detection of sentinel lymph node metastasis of breast cancer by digital PCR for RASSF1A methylation

por Abe, Mizuho, Kagara, Naofumi, Miyake, Tomohiro, Tanei, Tomonori, Naoi, Yasuto, Shimoda, Masafumi, Shimazu, Kenzo, Kim, Seung Jin, Noguchi, Shinzaburo
Publicado 2019

The Feasibility of Omitting Postoperative Radiotherapy in Japanese Patients With Ductal Carcinoma In Situ of Breast Treated With Breast-Conserving Surgery

por Nakashima, Akihiro, Yamazaki, Hideya, Suzuki, Gen, Yamada, Kei, Norihiro, Aibe, Kimoto, Takuya, Masui, Koji, Nakatsuka, Katsuhiko, Taguchi, Tetsuya, Naoi, Yasuto
Publicado 2023

BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer

por Otani, Yoko, Miyake, Tomohiro, Kagara, Naofumi, Shimoda, Masafumi, Naoi, Yasuto, Maruyama, Naomi, Shimomura, Atsuhi, Shimazu, Kenzo, Kim, Seung Jin, Noguchi, Shinzaburo
Publicado 2014

Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients

por Mishima, Chieko, Kagara, Naofumi, Matsui, Saki, Tanei, Tomonori, Naoi, Yasuto, Shimoda, Masafumi, Shimomura, Atsushi, Shimazu, Kenzo, Kim, Seung Jin, Noguchi, Shinzaburo
Publicado 2015

Enhanced humoral immunity in breast cancer patients with high serum concentration of anti‐HER2 autoantibody

por Sato, Yasufumi, Shimoda, Masafumi, Sota, Yoshiaki, Miyake, Tomohiro, Tanei, Tomonori, Kagara, Naofumi, Naoi, Yasuto, Kim, Seung Jin, Noguchi, Shinzaburo, Shimazu, Kenzo
Publicado 2021

Molecular Barcode Sequencing of the Whole Ligand Binding Domain of the ESR1 Gene in Cell-Free DNA from Patients with Metastatic Breast Cancer()

por Masunaga, Nanae, Kagara, Naofumi, Motooka, Daisuke, Nakamura, Shota, Miyake, Tomohiro, Tanei, Tomonori, Naoi, Yasuto, Shimoda, Masafumi, Shimazu, Kenzo, Kim, Seung Jin, Noguchi, Shinzaburo
Publicado 2020

Detection of ctDNA with Personalized Molecular Barcode NGS and Its Clinical Significance in Patients with Early Breast Cancer

por Yoshinami, Tetsuhiro, Kagara, Naofumi, Motooka, Daisuke, Nakamura, Shota, Miyake, Tomohiro, Tanei, Tomonori, Naoi, Yasuto, Shimoda, Masafumi, Shimazu, Kenzo, Kim, Seung Jin, Noguchi, Shinzaburo
Publicado 2020

Endocrine sensitivity of estrogen receptor‐positive breast cancer is negatively correlated with aspartate‐β‐hydroxylase expression

por Shimoda, Masafumi, Hori, Ami, Wands, Jack R., Tsunashima, Ryo, Naoi, Yasuto, Miyake, Tomohiro, Tanei, Tomonori, Kagara, Naofumi, Shimazu, Kenzo, Kim, Seung Jin, Noguchi, Shinzaburo
Publicado 2017

Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis

por FUJITA, NORIKO, KAGARA, NAOFUMI, YAMAMOTO, NORIAKI, SHIMAZU, KENZO, SHIMOMURA, ATSUSHI, SHIMODA, MASAFUMI, MARUYAMA, NAOMI, NAOI, YASUTO, MORIMOTO, KOJI, ODA, NAOFUMI, KIM, SEUNG JIN, NOGUCHI, SHINZABURO
Publicado 2014

Identification of sentinel lymph nodes by contrast‐enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals

por Shimazu, Kenzo, Ito, Toshikazu, Uji, Kumiko, Miyake, Tomohiro, Aono, Toyokazu, Motomura, Kazuyoshi, Naoi, Yasuto, Shimomura, Atsushi, Shimoda, Masafumi, Kagara, Naofumi, Kim, Seung Jin, Noguchi, Shinzaburo
Publicado 2017

Determining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancer

por Kim, Seung Jin, Sota, Yoshiaki, Naoi, Yasuto, Honma, Keiichiro, Kagara, Naofumi, Miyake, Tomohiro, Shimoda, Masafumi, Tanei, Tomonori, Seno, Shigeto, Matsuda, Hideo, Noguchi, Shinzaburo, Shimazu, Kenzo
Publicado 2020

Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest(™) 95GC Breast in a multi‑instit...

por Naoi, Yasuto, Tsunashima, Ryo, Shimazu, Kenzo, Oikawa, Masahiro, Imanishi, Seiichi, Koyama, Hiroshi, Kamada, Yoshihiko, Ishihara, Kazuhiro, Suzuki, Masahiko, Osako, Tomo, Kinoshita, Takayuki, Suto, Akihiko, Nakamura, Seigo, Tsuda, Hitoshi, Noguchi, Shinzaburo
Publicado 2023